The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities*
暂无分享,去创建一个
[1] Alfonso Valencia,et al. Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.
[2] H. Lother,et al. The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist* , 2001, The Journal of Biological Chemistry.
[3] M. Bouvier,et al. Hetero-oligomerization between β2- and β3-Adrenergic Receptors Generates a β-Adrenergic Signaling Unit with Distinct Functional Properties* , 2004, Journal of Biological Chemistry.
[4] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[5] S. Rees,et al. Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.
[6] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[7] B. Mouillac,et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. , 2003, Molecular endocrinology.
[8] P. Sexton,et al. G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor , 2005, Circulation.
[9] C. Martínez-A,et al. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Margeta-Mitrovic. Assembly-dependent trafficking assays in the detection of receptor-receptor interactions. , 2002, Methods.
[11] Mario Mellado,et al. Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.
[12] G. Milligan,et al. High-affinity interactions between human α1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the α1L-adrenoceptor , 2004 .
[13] B. O'dowd,et al. Oligomerization of opioid receptors: generation of novel signaling units. , 2002, Current opinion in pharmacology.
[14] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[15] Krzysztof Palczewski,et al. Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.
[16] Gregory J Babcock,et al. Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor* , 2003, The Journal of Biological Chemistry.
[17] Joseph Parello,et al. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.
[18] C. Browning,et al. Signalling by CXC‐chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPγS binding induced by IL‐8 and GROα , 1999, British journal of pharmacology.
[19] Michel Bouvier,et al. Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.
[20] Jean-François Mercier,et al. Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting* , 2004, Journal of Biological Chemistry.
[21] G. Milligan,et al. Multiple Interactions between Transmembrane Helices Generate the Oligomeric α1b-Adrenoceptor , 2004, Molecular Pharmacology.
[22] M. Parmentier,et al. Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.
[23] R. Eglen. Enzyme fragment complementation: a flexible high throughput screening assay technology. , 2002, Assay and drug development technologies.
[24] Jonathan A Javitch,et al. The Ants Go Marching Two by Two: Oligomeric Structure of G-Protein-Coupled Receptors , 2004, Molecular Pharmacology.
[25] Pietro Ghezzi,et al. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Martínez-A,et al. The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] Jean-François Mercier,et al. Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.
[28] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[29] B. O'dowd,et al. Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal* , 2004, Journal of Biological Chemistry.
[30] Xiaochun Sun,et al. Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer , 2005, Molecular Pharmacology.
[31] Y. Jan,et al. A New ER Trafficking Signal Regulates the Subunit Stoichiometry of Plasma Membrane KATP Channels , 1999, Neuron.
[32] L. Miller,et al. Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy Transfer* , 2001, The Journal of Biological Chemistry.
[33] D. Segaloff,et al. Constitutive and Agonist-dependent Self-association of the Cell Surface Human Lutropin Receptor* , 2004, Journal of Biological Chemistry.
[34] Michel Bouvier,et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.
[35] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[36] M. Esterman,et al. Neuropeptide Y Y4 Receptor Homodimers Dissociate upon Agonist Stimulation , 2003, Journal of Pharmacology and Experimental Therapeutics.
[37] K. Blumer,et al. G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.
[38] Cristina Limatola,et al. Ligand-independent CXCR2 Dimerization* , 2003, Journal of Biological Chemistry.
[39] Alan Wise,et al. Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.
[40] Graeme Milligan,et al. Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[41] Graeme Milligan,et al. G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.
[42] A. Cornea,et al. Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.
[43] Graeme Milligan,et al. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. , 2002, The Biochemical journal.
[44] A. Engel,et al. The G protein‐coupled receptor rhodopsin in the native membrane , 2004, FEBS letters.
[45] R. Latif,et al. Ligand-dependent Inhibition of Oligomerization at the Human Thyrotropin Receptor* , 2002, The Journal of Biological Chemistry.
[46] Gerda E Breitwieser,et al. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. , 2004, Circulation research.
[47] P. Fossier,et al. Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.
[48] D. Jenness,et al. Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis. , 2000, Molecular biology of the cell.
[49] H. Lother,et al. Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.
[50] C. Martínez-A,et al. Chemokine receptor dimerization: two are better than one. , 2001, Trends in immunology.
[51] M. von Zastrow,et al. The Composition of the β-2 Adrenergic Receptor Oligomer Affects Its Membrane Trafficking after Ligand-Induced Endocytosis , 2005, Molecular Pharmacology.
[52] J. Ballesteros,et al. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.
[53] R. Doi,et al. Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. , 2002, Experimental cell research.